(Q24323976)

GOA release 2020-03-11

bone morphogenesis

1 reference

GOA release 2020-03-11

1 reference

9

0 references

Christine Laine

5

Christine Laine

0 references

Ulla Lahtinen

Ulla Lahtinen

4

0 references

Tero Kivelä

Tero Kivelä

3

0 references

Outi Mäkitie

Outi Mäkitie

10

0 references

author name string

Anne Saarinen

1

0 references

Tero Saukkonen

2

0 references

Mirja Somer

6

0 references

Sanna Toiviainen-Salo

7

0 references

William G Cole

Expression of the type I diabetes-associated gene LRP5 in macrophages, vitamin A system cells, and the Islets of Langerhans suggests multiple potential roles in diabetes

8

0 references

language of work or name

English

0 references

publication date

April 2010

0 references

published in

Clinical Endocrinology

0 references

volume

72

0 references

issue

4

0 references

page(s)

481-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

Osteoporosis-pseudoglioma syndrome: report of three affected sibs and an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Osteoporosis-pseudoglioma syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Vertebral fracture assessment using a semiquantitative technique.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Linkage and association mapping of the LRP5 locus on chromosome 11q13 in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Low-density lipoprotein receptor-related protein 5 variant A1330V is a determinant of blood pressure in Japanese males.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

G-protein beta 3 subunit polymorphism C1429T and low-density lipoprotein receptor-related protein 5 polymorphism A1330V are risk factors for hypercholesterolemia in Japanese males--a prospective study over 5 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

High bone density due to a mutation in LDL-receptor-related protein 5

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Low-density lipoprotein receptor-related protein 5 variant Q89R is associated with hypertension in Japanese females.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Clinical and molecular findings in osteoporosis-pseudoglioma syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Osteoporosis-pseudoglioma syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

LRP6 mutation in a family with early coronary disease and metabolic risk factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Osteoporosis-pseudoglioma syndrome: clinical, morphological, and biochemical studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Low-density lipoprotein receptor-related protein 5 (LRP5) gene polymorphisms are associated with bone mass in both Chinese and whites.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021

Identification of individuals with insulin resistance using routine clinical measurements

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2009.03680.X

7 January 2021